Literature DB >> 19452382

Pregabalin in the treatment of schizophrenic anxiety.

C Schönfeldt-Lecuona, R C Wolf, N D Osterfeld, N Vasic, B J Connemann, M Schmid, R W Freudenmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19452382     DOI： 10.1055/s-0028-1112128

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  4 in total

1.  Treating anxious syndromes with pregabalin in patients with psychosis.

Authors:  Nicolas Garel; David Bloom; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

2.  Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.

Authors:  Katrin Druschky; Stefan Bleich; Renate Grohmann; Rolf R Engel; Alexandra Kleimann; Susanne Stübner; Waldemar Greil; Sermin Toto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-01       Impact factor: 5.270

3.  Involvement of the dopaminergic system in the reward-related behavior of pregabalin.

Authors:  Yusuf S Althobaiti; Farooq M Almutairi; Fahad S Alshehri; Ebtehal Altowairqi; Aliyah M Marghalani; Amal A Alghorabi; Walaa F Alsanie; Ahmed Gaber; Hashem O Alsaab; Atiah H Almalki; Alqassem Y Hakami; Turki Alkhalifa; Ahmad D Almalki; Ana M G Hardy; Zahoor A Shah
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

4.  Intranasal Pregabalin Administration: A Review of the Literature and the Worldwide Spontaneous Reporting System of Adverse Drug Reactions.

Authors:  Mohamed Elsayed; René Zeiss; Maximilian Gahr; Bernhard J Connemann; Carlos Schönfeldt-Lecuona
Journal:  Brain Sci       Date:  2019-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.